← Leaderboards
Eric C Johannsen
Brigham And Women'S Hospital
$4,978,414
Attributed
$6,425,601
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $944.8K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,425,601 · 6
By mechanism
R01$2,894,375 · 1
U01$1,746,152 · 1
P01$1,399,514 · 3
K08$385,560 · 1
Top collaborators
- Shannon Celeste Kenney5 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Frederick C. Wang$16,331,006
- Benjamin Elison Gewurz$12,892,911
- Chong Wang$1,369,010
- Rui Guo$978,211
- Kenneth M Kaye$21,944,697
Others in their field
Top investigators on “Human Herpesvirus 4”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$73,088,996
- Kristin Ardlie · Genomics Collaborative, Inc.$51,299,015
- Constance Ann Benson · University Of California, San Diego$36,890,085
- Donald Ym Leung · University Of Colorado Denver$32,964,660
- Louis J. Picker · Oregon Health And Science University$30,431,650
- Paul M. Lieberman · Wistar Institute$25,109,269
Research focus
Human Herpesvirus 4ViralCellsVirusHerpesviridaeB-LymphocytesPathway InteractionsGenomeMutantProteinsCharacteristicsGenesResponseGene ExpressionEpstein-Barr Virus InfectionsMediatingOncogenic VirusesHuman GeneticsMolecular GeneticsMolecular BiologyCollaborationsMutationCell LineLmp1
Grant awards (21)
Role of Epstein-Barr virus LMP2A protein in maintaining oncogenic IgM signaling in EBV+ B cell lymphomas$436,538
U01 · FY2025 · CA · contact PI
Project 4 - Defining the Role of EBV in DLBCL Pathogenesis and Identification of Therapeutic Targets$430,044
P01 · FY2025 · CA · contact PI
Core C - Virus/Vector$78,206
P01 · FY2025 · CA · contact PI
Role of Epstein-Barr virus LMP2A protein in maintaining oncogenic IgM signaling in EBV+ B cell lymphomas$436,538
U01 · FY2024 · CA · contact PI
Project 4 - Defining the Role of EBV in DLBCL Pathogenesis and Identification of Therapeutic Targets$430,044
P01 · FY2024 · CA · contact PI
Core C - Virus/Vector$78,206
P01 · FY2024 · CA · contact PI
Role of Epstein-Barr virus LMP2A protein in maintaining oncogenic IgM signaling in EBV+ B cell lymphomas$436,538
U01 · FY2023 · CA · contact PI
Role of Epstein-Barr virus LMP2A protein in maintaining oncogenic IgM signaling in EBV+ B cell lymphomas$436,538
U01 · FY2022 · CA · contact PI
Core C - Virus Core$78,528
P01 · FY2022 · CA · contact PI
Core C - Virus Core$83,066
P01 · FY2021 · CA · contact PI
Core C - Virus Core$76,647
P01 · FY2020 · CA · contact PI
Core C - Virus Core$68,126
P01 · FY2019 · CA · contact PI
Core C - Virus Core$76,647
P01 · FY2018 · CA · contact PI
Epigenetic determinants of Epstein-Barr virus and cellular DNA in oral diseases$578,875
R01 · FY2017 · DE · contact PI
Epigenetic determinants of Epstein-Barr virus and cellular DNA in oral diseases$578,875
R01 · FY2016 · DE · contact PI
Epigenetic determinants of Epstein-Barr virus and cellular DNA in oral diseases$578,875
R01 · FY2015 · DE · contact PI
Epigenetic determinants of Epstein-Barr virus and cellular DNA in oral diseases$578,875
R01 · FY2014 · DE · contact PI
Epigenetic determinants of Epstein-Barr virus and cellular DNA in oral diseases$578,875
R01 · FY2013 · DE · contact PI
EBNA-3C in B Lymphocyte Transformation by EBV$128,520
K08 · FY2003 · AI
EBNA-3C in B Lymphocyte Transformation by EBV$128,520
K08 · FY2002 · AI
EBNA-3C in B Lymphocyte Transformation by EBV$128,520
K08 · FY2001 · AI